Kaarin Mäkikallio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kaarin Mäkikallio has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Juha Räsänen
Fetal Medicine Center, Department of Obstetrics and Gynecology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
3 shared publications Olli Vuolteenaho
Department of Physiology, Biocenter Oulu, University of Oulu, Oulu, Finland
3 shared publicationsA. Tekay
2 shared publicationsAydin Tekay
Department of Obstetrics and Gynecology and PEDEGO Research Unit, Oulu University Hospital and University of Oulu, Oulu, Finland
2 shared publicationsJuha Räsänen
2 shared publicationsP. Jouppila
2 shared publications
Latest Publications
- 29 December 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (1) , 69-77
Fetal hemodynamics and adverse outcome in primary school‐aged children with fetal growth restriction: a prospective longitudinal study
Introduction: Fetal growth restriction is associated with short‐term and long‐term mortality and morbidity. We hypothesized that adverse outcome in children with fetal growth restriction at primary school age is associated with fetoplacental circulatory abnormalities.Material and methods: Comprehensive ultrasonographic assessment of fetoplacental hemodynamics was performed in 72 growth‐restricted fetuses prenatally, and short‐term outcome data were collected. At the median age of 9 years, mortality and morbidity were determined using medical charts and questionnaires. The impact of abnormal fetoplacental hemodynamics on mortality and morbidity with significant developmental disorders or delay were studied.Results: Fetal growth restriction children with adverse long‐term outcome were delivered earlier and with lower birthweights than were those with non‐compromised outcome. Seventy percent of the fetal growth restriction group showed non‐compromised long‐term outcomes and participated in mainstream education at the appropriate age level. Absent/retrograde diastolic flow in the umbilical artery (p < 0.001), negative A‐wave in the ductus venosus (p = 0.006), cardiomegaly (p = 0.02), hydrops (p = 0.006) and cardiovascular profile score p = 0.002) were associated with increased risk of adverse outcome. After adjustment for gestational age, these parameters demonstrated hazard ratios of 5.0–16.5 for adverse long‐term outcome; increased systemic venous pulsatility and low cardiovascular profile score had the highest predictive power.Conclusions: Absent or reversed end‐diastolic flow in the umbilical artery, reversed A‐wave in the ductus venosus, cardiomegaly, hydrops, and low cardiovascular profile score are associated with adverse outcomes at primary school age in fetal growth restriction children. These fetal parameters play a significant role in the prediction of long‐term outcomes for fetal growth restriction children.
- 29 December 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 96 (1) , 69-77
Fetal hemodynamics and adverse outcome in primary school‐aged children with fetal growth restriction: a prospective longitudinal study
Introduction: Fetal growth restriction is associated with short‐term and long‐term mortality and morbidity. We hypothesized that adverse outcome in children with fetal growth restriction at primary school age is associated with fetoplacental circulatory abnormalities.Material and methods: Comprehensive ultrasonographic assessment of fetoplacental hemodynamics was performed in 72 growth‐restricted fetuses prenatally, and short‐term outcome data were collected. At the median age of 9 years, mortality and morbidity were determined using medical charts and questionnaires. The impact of abnormal fetoplacental hemodynamics on mortality and morbidity with significant developmental disorders or delay were studied.Results: Fetal growth restriction children with adverse long‐term outcome were delivered earlier and with lower birthweights than were those with non‐compromised outcome. Seventy percent of the fetal growth restriction group showed non‐compromised long‐term outcomes and participated in mainstream education at the appropriate age level. Absent/retrograde diastolic flow in the umbilical artery (p < 0.001), negative A‐wave in the ductus venosus (p = 0.006), cardiomegaly (p = 0.02), hydrops (p = 0.006) and cardiovascular profile score p = 0.002) were associated with increased risk of adverse outcome. After adjustment for gestational age, these parameters demonstrated hazard ratios of 5.0–16.5 for adverse long‐term outcome; increased systemic venous pulsatility and low cardiovascular profile score had the highest predictive power.Conclusions: Absent or reversed end‐diastolic flow in the umbilical artery, reversed A‐wave in the ductus venosus, cardiomegaly, hydrops, and low cardiovascular profile score are associated with adverse outcomes at primary school age in fetal growth restriction children. These fetal parameters play a significant role in the prediction of long‐term outcomes for fetal growth restriction children.
- 15 April 2016
- Published by Wiley in Prenatal Diagnosis
- Vol. 36 (7) , 622-627
Placental and fetal hemodynamics in prolonged pregnancies
What's Already Known About This Topic? Risk for an adverse outcome is increased in prolonged pregnancies. Nulliparity and oligohydramnios are independent risk factors for adverse outcome in prolonged pregnancies. What Does This Study Add? Comprehensive Doppler assessments of placental and fetal central and peripheral hemodynamics prior to the induction of labor do not differ in prolonged pregnancies with favorable and unfavorable outcomes, indicating that their value is limited in the intermittent fetal surveillance and in the prediction of adverse outcomes in prolonged pregnancies.
- 15 April 2016
- Published by Wiley in Prenatal Diagnosis
- Vol. 36 (7) , 622-627
Placental and fetal hemodynamics in prolonged pregnancies
What's Already Known About This Topic? Risk for an adverse outcome is increased in prolonged pregnancies. Nulliparity and oligohydramnios are independent risk factors for adverse outcome in prolonged pregnancies. What Does This Study Add? Comprehensive Doppler assessments of placental and fetal central and peripheral hemodynamics prior to the induction of labor do not differ in prolonged pregnancies with favorable and unfavorable outcomes, indicating that their value is limited in the intermittent fetal surveillance and in the prediction of adverse outcomes in prolonged pregnancies.
- 19 September 2015
- Published by Springer Nature in Heart and Vessels
- Vol. 31 (9) , 1504-1513
Fetal growth restriction and cardiovascular outcome in early human infancy: a prospective longitudinal study
The association between low birth weight and premature cardiovascular disease has led to the “prenatal origin of adult disease-hypothesis”. We postulated that fetal growth restriction is associated with cardiovascular changes detectable at birth and in early infancy. Fifty-two appropriately grown fetuses (AGA) and 60 growth-restricted fetuses (FGR) with (n = 20) or without (n = 40) absent or reversed end-diastolic umbilical artery blood flow were prospectively examined by echocardiography before birth, at 1 week and 6 months of life. The impact of growth restriction on postnatal blood pressure, heart rate, cardiovascular dimensions, and function, as well as on vascular morphology of umbilical cord vessels was studied. FGR fetuses displayed significant blood flow redistribution and were delivered earlier with lower birth weights than AGA fetuses. After adjustment for gender, gestational age, and weight at birth, there were no intergroup differences in blood pressure, heart rate, left ventricular morphology, mass, and performance, and in cord vessel morphology. During the first 6 months of life brachioradial pulse wave velocity increased more in FGR fetuses, while other parameters describing vascular stiffness remained comparable between the groups. Fetal growth restriction had no detectable adverse impact on cardiovascular dimensions and function at birth. Cardiovascular findings also remained comparable during the first 6 months of life between the groups except a higher increase in brachioradial pulse wave velocity in the FGR group. Our observations suggest that abnormalities that link reduced intrauterine growth with premature cardiovascular diseases may commence later in childhood, indicating a potential window for screening and prevention.
- 19 September 2015
- Published by Springer Nature in Heart and Vessels
- Vol. 31 (9) , 1504-1513
Fetal growth restriction and cardiovascular outcome in early human infancy: a prospective longitudinal study
The association between low birth weight and premature cardiovascular disease has led to the “prenatal origin of adult disease-hypothesis”. We postulated that fetal growth restriction is associated with cardiovascular changes detectable at birth and in early infancy. Fifty-two appropriately grown fetuses (AGA) and 60 growth-restricted fetuses (FGR) with (n = 20) or without (n = 40) absent or reversed end-diastolic umbilical artery blood flow were prospectively examined by echocardiography before birth, at 1 week and 6 months of life. The impact of growth restriction on postnatal blood pressure, heart rate, cardiovascular dimensions, and function, as well as on vascular morphology of umbilical cord vessels was studied. FGR fetuses displayed significant blood flow redistribution and were delivered earlier with lower birth weights than AGA fetuses. After adjustment for gender, gestational age, and weight at birth, there were no intergroup differences in blood pressure, heart rate, left ventricular morphology, mass, and performance, and in cord vessel morphology. During the first 6 months of life brachioradial pulse wave velocity increased more in FGR fetuses, while other parameters describing vascular stiffness remained comparable between the groups. Fetal growth restriction had no detectable adverse impact on cardiovascular dimensions and function at birth. Cardiovascular findings also remained comparable during the first 6 months of life between the groups except a higher increase in brachioradial pulse wave velocity in the FGR group. Our observations suggest that abnormalities that link reduced intrauterine growth with premature cardiovascular diseases may commence later in childhood, indicating a potential window for screening and prevention.
- 1 January 2015
- Vol. 131 (12) , 1137-43
[Evidence-based cesarean section].
Cesarean delivery is the most frequent major surgery in Finland: in 2013 over 16% of the deliveries were via cesarean route. 27% of the mothers are estimated to face complications. Optimal surgical techniques and other operation-related measures aim to reduce the incidence of complications. Recommendations favor preoperative antibiotics, vaginal preparation, transversal skin incision, non-development of bladder flap, blunt cephalo-caudad uterine extension, spontaneous placental removal, late cord clamping, continuous sutures for uterine closure and subcutaneous skin sutures. Optimal measures will not only reduce complications in cesarean deliveries but bring cost savings and unify the clinical routines and training in specialization programs.
- 1 January 2015
- Vol. 131 (12) , 1137-43
[Evidence-based cesarean section].
Cesarean delivery is the most frequent major surgery in Finland: in 2013 over 16% of the deliveries were via cesarean route. 27% of the mothers are estimated to face complications. Optimal surgical techniques and other operation-related measures aim to reduce the incidence of complications. Recommendations favor preoperative antibiotics, vaginal preparation, transversal skin incision, non-development of bladder flap, blunt cephalo-caudad uterine extension, spontaneous placental removal, late cord clamping, continuous sutures for uterine closure and subcutaneous skin sutures. Optimal measures will not only reduce complications in cesarean deliveries but bring cost savings and unify the clinical routines and training in specialization programs.
- Open Access
- 2 September 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 1-8
Gestational pemphigoid
Gestational pemphigoid (pemphigoid gestationis, PG) is a rare autoimmune skin disorder occurring characteristically during pregnancy. Autoantibodies against placental BP180 (also known as BPAG2 or collagen XVII) cause damage to the skin basement membrane, resulting in severe itching and blistering rash over the body and the extremities. The diagnosis of PG is confirmed by immunofluorescence analysis of a skin biopsy, while serum levels of pemphigoid antigen BP180 antibody can be used to assess disease activity. PG with mild symptoms can be treated with topical corticosteroids, while oral corticosteroids are the mainstay in treatment of severe PG. PG usually flares up at the time of delivery, and resolves spontaneously shortly after. However, relapses in subsequent pregnancies are common. As PG has been linked to the risk of prematurity and fetal growth restriction, prenatal monitoring jointly by a dermatologist and an obstetrician is recommended. Mothers should also be informed of the potential risk of re-activation of the disease in subsequent pregnancies and during hormonal contraception.
- 2 September 2014
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 9 (1) , 1-8
Open AccessGestational pemphigoid
Gestational pemphigoid (pemphigoid gestationis, PG) is a rare autoimmune skin disorder occurring characteristically during pregnancy. Autoantibodies against placental BP180 (also known as BPAG2 or collagen XVII) cause damage to the skin basement membrane, resulting in severe itching and blistering rash over the body and the extremities. The diagnosis of PG is confirmed by immunofluorescence analysis of a skin biopsy, while serum levels of pemphigoid antigen BP180 antibody can be used to assess disease activity. PG with mild symptoms can be treated with topical corticosteroids, while oral corticosteroids are the mainstay in treatment of severe PG. PG usually flares up at the time of delivery, and resolves spontaneously shortly after. However, relapses in subsequent pregnancies are common. As PG has been linked to the risk of prematurity and fetal growth restriction, prenatal monitoring jointly by a dermatologist and an obstetrician is recommended. Mothers should also be informed of the potential risk of re-activation of the disease in subsequent pregnancies and during hormonal contraception.
- Open Access
- 1 January 2008
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 87 (3) , 307-312
Increased fetal cardiac natriuretic peptide secretion in type-1 diabetic pregnancies
Background. We hypothesised that human fetal cardiac natriuretic peptide secretion is increased in type-1 diabetic pregnancies with normal placental hemodynamics, and this increase is related to the first trimester maternal glycemic control. Methods. Thirty-two neonates of type-1 diabetic mothers and 60 neonates born after uncomplicated pregnancy and labour (control group) were included in this study. Diabetic pregnancies were divided into two subgroups based on the first trimester HbA1c value. Group 1 pregnancies (n =22) had a good glycemic control (HbA1c n =10) had a poor glycemic control (HbA1c ≥7.5%). At delivery, an umbilical artery (UA) blood sample was obtained for assessment of N-terminal peptide of proatrial (NT-proANP) and proB-type (NT-proBNP) natriuretic peptide levels. In diabetic pregnancies, each fetus had normal UA Doppler velocimetry for gestational age. Results. The newborn UA NT-proANP and NT-proBNP concentrations were significantly higher in type-1 diabetic pregnancies than in the control group. Group 2 fetuses with poor glycemic control showed significantly higher UA NT-proANP levels than Group 1 fetuses. UA NT-proANP levels correlated significantly with maternal HbA1c values in the first, second and third trimesters, while UA NT-proBNP levels did not correlate with maternal HbA1c values. Conclusions. In type-1 diabetic pregnancies, fetal cardiac natriuretic peptide secretion is increased, even in the presence of good glycemic control and normal placental hemodynamics. In addition, fetal NT-proANP levels are already related to maternal glycemic control in the first trimester of pregnancy.
- 1 January 2008
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 87 (3) , 307-312
Open AccessIncreased fetal cardiac natriuretic peptide secretion in type-1 diabetic pregnancies
Background. We hypothesised that human fetal cardiac natriuretic peptide secretion is increased in type-1 diabetic pregnancies with normal placental hemodynamics, and this increase is related to the first trimester maternal glycemic control. Methods. Thirty-two neonates of type-1 diabetic mothers and 60 neonates born after uncomplicated pregnancy and labour (control group) were included in this study. Diabetic pregnancies were divided into two subgroups based on the first trimester HbA1c value. Group 1 pregnancies (n =22) had a good glycemic control (HbA1c n =10) had a poor glycemic control (HbA1c ≥7.5%). At delivery, an umbilical artery (UA) blood sample was obtained for assessment of N-terminal peptide of proatrial (NT-proANP) and proB-type (NT-proBNP) natriuretic peptide levels. In diabetic pregnancies, each fetus had normal UA Doppler velocimetry for gestational age. Results. The newborn UA NT-proANP and NT-proBNP concentrations were significantly higher in type-1 diabetic pregnancies than in the control group. Group 2 fetuses with poor glycemic control showed significantly higher UA NT-proANP levels than Group 1 fetuses. UA NT-proANP levels correlated significantly with maternal HbA1c values in the first, second and third trimesters, while UA NT-proBNP levels did not correlate with maternal HbA1c values. Conclusions. In type-1 diabetic pregnancies, fetal cardiac natriuretic peptide secretion is increased, even in the presence of good glycemic control and normal placental hemodynamics. In addition, fetal NT-proANP levels are already related to maternal glycemic control in the first trimester of pregnancy.
- 21 December 2007
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (1) , 6-9
Is it time to add aortic isthmus evaluation to the repertoire of Doppler investigations for placental insufficiency?
- 21 December 2007
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (1) , 6-9
Is it time to add aortic isthmus evaluation to the repertoire of Doppler investigations for placental insufficiency?
- Open Access
- 11 December 2007
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (1) , 48-54
Human fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction
Objective: To determine whether low cardiovascular profile (CVP) score has prognostic value for predicting neonatal mortality and severe morbidity in human fetuses with growth restriction.Methods: Seventy‐five consecutive growth‐restricted fetuses with Doppler examination of cardiovascular hemodynamics within a week prior to delivery comprised the study population. Hydrops, heart size, cardiac function and venous and arterial hemodynamics were evaluated for CVP score. The primary outcome measures were neonatal mortality and cerebral palsy.Results: During the neonatal period, six of 75 neonates died and two had cerebral palsy (Group 1, n = 8). Compared with the fetuses discharged home from hospital (Group 2, n = 67), those in Group 1 were delivered at an earlier gestational age (28 (range, 24–35) weeks vs. 35 (range, 26–40) weeks, P < 0.01) and had lower CVP scores (4 (range, 2–6) vs. 9 (range, 5–10), P < 0.0001). All CVP subscale scores were lower (P < 0.01) in Group 1 than in Group 2 fetuses. Gestational age‐adjusted hazard ratios (95% CIs) for adverse neonatal outcome were highest for cardiomegaly (13.9 (1.7–114.3), P = 0.014), monophasic atrioventricular filling pattern or holosystolic tricuspid regurgitation (9.5 (2.3–38.4), P = 0.002) and atrial pulsations in the umbilical vein 7.7 (1.4–41.2), P = 0.017).Conclusions: Growth‐restricted fetuses with adverse neonatal outcome have lower CVP scores than do fetuses with favorable neonatal outcome. The strongest predictors for adverse neonatal outcome in the CVP score were cardiomegaly, abnormal cardiac function with monophasic atrioventricular filling or holosystolic tricuspid regurgitation and increased systemic venous pressure. These assessments have independent prognostic power for adverse neonatal outcome even after adjustment for gestational age. Copyright © 2007 ISUOG. Published by John Wiley & Sons, Ltd.
- 11 December 2007
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (1) , 48-54
Open AccessHuman fetal cardiovascular profile score and neonatal outcome in intrauterine growth restriction
Objective: To determine whether low cardiovascular profile (CVP) score has prognostic value for predicting neonatal mortality and severe morbidity in human fetuses with growth restriction.Methods: Seventy‐five consecutive growth‐restricted fetuses with Doppler examination of cardiovascular hemodynamics within a week prior to delivery comprised the study population. Hydrops, heart size, cardiac function and venous and arterial hemodynamics were evaluated for CVP score. The primary outcome measures were neonatal mortality and cerebral palsy.Results: During the neonatal period, six of 75 neonates died and two had cerebral palsy (Group 1, n = 8). Compared with the fetuses discharged home from hospital (Group 2, n = 67), those in Group 1 were delivered at an earlier gestational age (28 (range, 24–35) weeks vs. 35 (range, 26–40) weeks, P < 0.01) and had lower CVP scores (4 (range, 2–6) vs. 9 (range, 5–10), P < 0.0001). All CVP subscale scores were lower (P < 0.01) in Group 1 than in Group 2 fetuses. Gestational age‐adjusted hazard ratios (95% CIs) for adverse neonatal outcome were highest for cardiomegaly (13.9 (1.7–114.3), P = 0.014), monophasic atrioventricular filling pattern or holosystolic tricuspid regurgitation (9.5 (2.3–38.4), P = 0.002) and atrial pulsations in the umbilical vein 7.7 (1.4–41.2), P = 0.017).Conclusions: Growth‐restricted fetuses with adverse neonatal outcome have lower CVP scores than do fetuses with favorable neonatal outcome. The strongest predictors for adverse neonatal outcome in the CVP score were cardiomegaly, abnormal cardiac function with monophasic atrioventricular filling or holosystolic tricuspid regurgitation and increased systemic venous pressure. These assessments have independent prognostic power for adverse neonatal outcome even after adjustment for gestational age. Copyright © 2007 ISUOG. Published by John Wiley & Sons, Ltd.
- 1 February 2006
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 194 (2) , 542-550
Fetal oxygenation and Doppler ultrasonography of cardiovascular hemodynamics in a chronic near-term sheep model
- 1 February 2006
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 194 (2) , 542-550
Fetal oxygenation and Doppler ultrasonography of cardiovascular hemodynamics in a chronic near-term sheep model